title: Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
authors.forename: Jodie A
authors.initials: JA
authors.lastname: Barkin
authors.forename: Heather M
authors.initials: HM
authors.lastname: Block
authors.forename: Paul E
authors.initials: PE
authors.lastname: Mendez
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D005260:Female; D005905:Glyburide / Q000009:adverse effects; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000009:adverse effects; D008687:Metformin / Q000009:adverse effects; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; C417231:Glucovance; D007004:Hypoglycemic Agents; D008687:Metformin; D015282:Octreotide; D005905:Glyburide